Acadia Healthcare (NASDAQ:ACHC) will be posting its quarterly earnings results after the market closes on Wednesday, February 21st. Analysts expect Acadia Healthcare to post earnings of $0.54 per share for the quarter.

Acadia Healthcare (NASDAQ:ACHC) opened at $36.32 on Monday. The company has a current ratio of 1.36, a quick ratio of 1.36 and a debt-to-equity ratio of 1.30. Acadia Healthcare has a twelve month low of $26.92 and a twelve month high of $54.34. The company has a market cap of $3,190.86, a P/E ratio of 18.44, a price-to-earnings-growth ratio of 1.22 and a beta of 0.85.

In other news, Director Reeve B. Waud sold 100,000 shares of the business’s stock in a transaction that occurred on Friday, December 15th. The shares were sold at an average price of $31.80, for a total transaction of $3,180,000.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 11.10% of the stock is currently owned by insiders.

Several research analysts have commented on the stock. Jefferies Group set a $42.00 price target on shares of Acadia Healthcare and gave the stock a “buy” rating in a report on Wednesday, October 25th. Zacks Investment Research upgraded shares of Acadia Healthcare from a “sell” rating to a “hold” rating in a research report on Monday, February 12th. Craig Hallum restated a “buy” rating and set a $41.00 price objective (down previously from $65.00) on shares of Acadia Healthcare in a research report on Thursday, October 26th. Bank of America reduced their price objective on shares of Acadia Healthcare from $60.00 to $52.00 and set a “buy” rating for the company in a research report on Wednesday, October 25th. Finally, Robert W. Baird downgraded shares of Acadia Healthcare from an “outperform” rating to a “neutral” rating and reduced their price objective for the stock from $55.00 to $38.00 in a research report on Wednesday, October 25th. Eight analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. Acadia Healthcare currently has an average rating of “Buy” and a consensus target price of $43.92.

COPYRIGHT VIOLATION NOTICE: This story was first reported by Watch List News and is the property of of Watch List News. If you are viewing this story on another website, it was illegally copied and reposted in violation of international trademark and copyright legislation. The correct version of this story can be viewed at

About Acadia Healthcare

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Earnings History for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with's FREE daily email newsletter.